The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

telecom
Predictive Networks: How Baron Weather and GIS are Strengthening Telecom Operations
February 12, 2026

Severe weather is no longer an occasional disruption for telecom providers—it’s becoming part of the operating environment. During Hurricane Ida in 2021, the Federal Communications Commission reported that nearly 1,000 cell sites across Louisiana and Mississippi went offline. In 2024, Hurricane Milton left more than 12% of cell sites in impacted areas of Florida…

Read More
The DAISY Foundation: Impacting Nurse Careers Through Recognition
The DAISY Foundation: Impacting Nurse Careers Through Recognition
February 12, 2026

Recognition is often described as a “nice to have” in healthcare, but on this episode of Care Anywhere, it’s framed as something far more essential. Host Lea Sims sits down with Deb Zimmermann, DNP, RN, NEA-BC, FAAN, Chief Executive Officer of The DAISY Foundation, and Bonnie Barnes, FAAN, co-founder of the organization, to explore…

Read More
Revpar Media
The Origin of Revpar Media: Host Calvin Tilokee’s Journey from Revenue Management to Performance Storytelling
February 11, 2026

Something has shifted in hotel marketing, and you can feel it. In a landscape where every property can publish polished visuals, aesthetics alone are no longer enough to stand out—or to convert attention into bookings. Research increasingly shows that social media now plays a meaningful role in how travelers choose destinations and plan trips,…

Read More
spiral growth
Spiral Growth: The Career Strategy That Builds Real Leaders
February 11, 2026

Leadership pipelines are under pressure. Companies are moving faster, roles are becoming more cross-functional, and high-potential talent is expected to deliver beyond narrow job descriptions earlier in their careers. At the same time, the World Economic Forum estimates that 39% of workers’ core skills will need to evolve by 2030 to keep pace with…

Read More